Levalbuterol Inhalation Solution Concentrate and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Levalbuterol Inhalation Solution Concentrate and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Levalbuterol inhalation, Levalbuterol
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Levalbuterol Inhalation Solution Concentrate-Tilia Fe
- Levalbuterol Inhalation Solution Concentrate-Tiludronate
- Levalbuterol Inhalation Solution Concentrate-Timentin
- Levalbuterol Inhalation Solution Concentrate-Timentin Add-Vantage
- Levalbuterol Inhalation Solution Concentrate-Timentin Injection
- Levalbuterol Inhalation Solution Concentrate-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Levalbuterol Inhalation, oral/nebulization
- Tildrakizumab-asmn Subcutaneous-Levamisole
- Tildrakizumab-asmn Subcutaneous-Levaquin
- Tildrakizumab-asmn Subcutaneous-Levaquin (Levofloxacin Injection)
- Tildrakizumab-asmn Subcutaneous-Levaquin (Levofloxacin Oral Solution)
- Tildrakizumab-asmn Subcutaneous-Levaquin (Levofloxacin Tablets)